The Amsler grid is a simple black grid on a white background — cheap enough to print at home for free. Yet it’s one of the most important tools for monitoring macular degeneration, the leading cause of irreversible vision loss in Americans over 50. The test itself costs nothing. The clinical context around it is where costs come in.
What Is the Amsler Grid and What Does It Detect?
The Amsler grid is a 10×10 cm grid of horizontal and vertical lines with a central dot. You cover one eye, hold it at reading distance, focus on the dot, and check whether any of the lines appear wavy, distorted, blurry, or missing.
Distortions or missing areas suggest changes in the macula — the central part of the retina responsible for detailed, straight-ahead vision. The Amsler grid is especially used to monitor:
- Age-related macular degeneration (AMD) — the NEI estimates that AMD affects more than 11 million Americans, with that number projected to double to nearly 22 million by 2050.
- Diabetic macular edema
- Central serous chorioretinopathy
- Epiretinal membrane
- Macular hole (early stages)
Positive findings on the Amsler grid don’t diagnose anything — they tell you and your eye doctor that further testing is warranted. That’s when the real cost picture begins.
The Cost of Macular Monitoring: From $0 to $400+
| Test or Service | What It Detects | Uninsured Cost | With Insurance |
|---|---|---|---|
| Amsler grid (printable/app) | Gross macular distortion | Free | Free |
| Fundus photography | Macular changes, drusen | $40–$80 (add-on) | Often covered |
| OCT (optical coherence tomography) | Retinal layers, fluid, membrane | $100–$250 | $20–$80 copay |
| Fluorescein angiography (FA) | Leaking blood vessels (wet AMD) | $200–$500 | $30–$100 copay |
| Amsler grid with medical eye exam | Baseline or monitoring exam | $100–$250 exam fee | Specialist copay |
| Electroretinography (ERG) | Retinal electrical function | $300–$700 | Partially covered |
| Microperimetry | Retinal sensitivity mapping | $150–$400 | Partially covered |
The Free Version: Home Monitoring
The Amsler grid you can print from the NEI website or use via smartphone apps (mVT — the macular vision test app) costs absolutely nothing. The AAO recommends that patients with intermediate AMD test their vision with an Amsler grid at home every day — it’s a tier-1 recommendation precisely because it catches rapid changes between clinical visits.
Apps like mySight (VSP) and ForeseeHome (a medical device that costs more — see below) offer more sensitive digital versions. But for most patients, the printed grid is sufficient home monitoring.
OCT: The Most Important Clinical Test
Optical coherence tomography (OCT) is the workhorse of macular monitoring. It creates a cross-sectional “slice” of the retina — like an ultrasound but using light — that shows your eye doctor the thickness, layers, and presence of fluid in the macula.
For AMD patients, OCT distinguishes dry from wet AMD and reveals subretinal fluid that signals the onset of wet AMD — the treatable form that responds to anti-VEGF injections (Eylea, Lucentis, Avastin, Vabysmo). Early detection of wet AMD conversion means starting injections sooner, which means better visual outcomes.
OCT costs $100–$250 uninsured. With medical insurance (Medicare or private), it’s covered as a diagnostic service — you pay your specialist copay, typically $20–$80. Medicare specifically covers OCT for AMD monitoring under HCPCS code 92134.
ForeseeHome is an FDA-cleared device that patients use at home daily — like a computerized Amsler grid that sends data to a monitoring center. Studies show it detects wet AMD conversion an average of 3.5 months earlier than self-administered home Amsler testing. Medicare covers ForeseeHome under DME benefit for qualified intermediate AMD patients. Without coverage, it costs $50–$100/month to lease.
What Triggers a Macular Testing Visit?
You should see an eye care provider for macular testing if:
- You notice distortion, waviness, or a “hole” in your central vision on the Amsler grid
- Your existing AMD (dry) seems to be changing
- You’re over 60 and haven’t had a dilated eye exam in more than a year
- You have diabetes and haven’t had a diabetic eye exam this year
- You have a family history of macular degeneration
The NEI recommends that people with risk factors for AMD (family history, smokers, over 55) have a dilated eye exam at least every 1–2 years. For those already diagnosed with AMD, more frequent monitoring — every 3–12 months depending on stage — is standard.
Does Insurance Cover Macular Testing?
Medical insurance: OCT, fluorescein angiography, fundus photography for diagnostic purposes, and medical exam visits related to macular conditions are covered under your medical insurance — not your vision plan. The visit is coded as a medical eye exam, not a routine refraction exam.
Medicare: Covers OCT for AMD (HCPCS 92134), fluorescein angiography (92235), and medical eye exams (92014). You pay 20% coinsurance after your Part B deductible.
Vision insurance: Does not cover diagnostic macular testing. Vision plans cover routine refraction and glasses — not medical eye disease monitoring.
If you’re diagnosed with any stage of AMD, switch your annual monitoring visit from your “vision plan” benefit to your medical insurance benefit. The diagnostic tests needed for AMD monitoring are medical — coded differently and covered differently. Your eye doctor’s billing staff can guide this, but you should ask explicitly.
What Happens If Something Is Found?
If OCT shows fluid or your Amsler grid reveals new distortion:
- Wet AMD: Anti-VEGF injections (Eylea, Lucentis, Vabysmo, Avastin) are the standard of care. These cost $1,200–$2,800 per injection list price, covered by medical insurance. For Medicare patients, the 20% coinsurance on a $2,000 injection is $400 — a supplemental Medigap policy covers this. You’ll need injections every 4–12 weeks indefinitely.
- Dry AMD: No pharmacological treatment currently reverses it, but AREDS2 supplements (vitamins C, E, zinc, lutein, zeaxanthin) reduce progression risk by about 25% in intermediate AMD. These cost $25–$50/month OTC.
Practical Takeaways on Macular Testing Costs
- Download a free Amsler grid from NEI.nih.gov and test each eye weekly if you’re over 55 or have AMD risk factors.
- Bill macular monitoring visits to medical insurance, not vision insurance.
- Use your HSA/FSA for OCT out-of-pocket costs — fully eligible.
- Ask about ForeseeHome if you have intermediate AMD and have Medicare — it’s covered as DME and provides much more sensitive monitoring than a paper grid.
- Don’t skip your annual dilated exam — AMD has no symptoms in early stages. Clinical detection before symptoms develop leads to better outcomes.
Macular testing itself isn’t expensive. The cost comes later — in treatment — and earlier detection consistently leads to better visual outcomes at lower cumulative treatment costs.